featured
Long-Term Risk of Heart Failure in Breast Cancer Patients After Adjuvant Chemotherapy With or Without Trastuzumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JACC: Heart Failure
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-Term Risk of Heart Failure in Breast Cancer Patients After Adjuvant Chemotherapy With or Without Trastuzumab
JACC Heart Fail 2019 Mar 01;7(3)217-224, A Banke, EL Fosbøl, M Ewertz, L Videbæk, JS Dahl, MK Poulsen, S Cold, MB Jensen, GH Gislason, M Schou, JE MøllerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.